Biotech · Private company · Alpharetta, GA, US
Clearside Biomedical, Inc.
SEC CIK 0001539029
Track this companyFree. Adds Clearside Biomedical, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials140 recruiting or active
Pipeline programs18From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline18
- 4 mg CLS-TA Suprachoriodal InjectionPhase 3 · UveitisClinicalTrials.gov · fetched Nov 12, 2026
- 4mg CLS-TA Suprachoriodal InjectionPhase 3 · UveitisClinicalTrials.gov · fetched Nov 12, 2026
- IVT afliberceptPhase 3 · Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- Lucentis or AvastinPhase 3 · Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- Sham ProcedurePhase 3 · UveitisClinicalTrials.gov · fetched Nov 12, 2026
- suprachoroidal CLS-TAPhase 3 · Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- suprachoroidal shamPhase 3 · Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- 0.8 mg CLS-TAPhase 2 · UveitisClinicalTrials.gov · fetched Nov 12, 2026
- 4 mg CLS-TAPhase 2 · Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- 4 mg CLS-TAPhase 2 · UveitisClinicalTrials.gov · fetched Nov 12, 2026
- AfliberceptPhase 2 · Neovascular Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- Anti-VEGFPhase 2 · Neovascular Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- CLS-AXPhase 2 · Neovascular Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- IVT AfliberceptPhase 2 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- SC CLS-TAPhase 2 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- ShamPhase 2 · Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- Sham SCPhase 2 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- triamcinolone acetonide (Triesence®)Phase 2 · UveitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials14
- Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular DegenerationPHASE2 · COMPLETED · started May 31, 2023ClinicalTrials.gov NCT05891548 · fetched Nov 12, 2026
- Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 StudyCOMPLETED · started Oct 8, 2021ClinicalTrials.gov NCT05131646 · fetched Nov 12, 2026
- Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMDPHASE1_PHASE2 · COMPLETED · started Dec 15, 2020ClinicalTrials.gov NCT04626128 · fetched Nov 12, 2026
- Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVOPHASE3 · TERMINATED · started Mar 5, 2018ClinicalTrials.gov NCT03203447 · fetched Nov 12, 2026
- MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301COMPLETED · started Dec 13, 2017ClinicalTrials.gov NCT02952001 · fetched Nov 12, 2026
- Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular EdemaPHASE2 · COMPLETED · started Jul 11, 2017ClinicalTrials.gov NCT03126786 · fetched Nov 12, 2026
- Suprachoroidal Injection of CLS-TA in Patients With Non-infectious UveitisPHASE3 · COMPLETED · started Apr 4, 2017ClinicalTrials.gov NCT03097315 · fetched Nov 12, 2026
- Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVOPHASE3 · TERMINATED · started Jan 31, 2017ClinicalTrials.gov NCT02980874 · fetched Nov 12, 2026
- Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular EdemaPHASE1_PHASE2 · COMPLETED · started Nov 10, 2016ClinicalTrials.gov NCT02949024 · fetched Nov 12, 2026
- Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02956330 · fetched Nov 12, 2026
- Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious UveitisPHASE3 · COMPLETED · started Nov 17, 2015ClinicalTrials.gov NCT02595398 · fetched Nov 12, 2026
- Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVOPHASE2 · COMPLETED · started Jan 1, 2015ClinicalTrials.gov NCT02303184 · fetched Nov 12, 2026
- Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious UveitisPHASE2 · COMPLETED · started Oct 1, 2014ClinicalTrials.gov NCT02255032 · fetched Nov 12, 2026
- Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat UveitisPHASE1_PHASE2 · COMPLETED · started Feb 1, 2013ClinicalTrials.gov NCT01789320 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Dec 29, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 8, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 25, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 14, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 7, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 11, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 11, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 8, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 3, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 14, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 8, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 17, 2025 · fetched Nov 12, 2026